Spray Dried Biologics For Injectable Dosage Forms

By Dr. Richard Johnson, Chief Scientific Officer

Spray drying is emerging as a transformative technology for the formulation and delivery of biologics in injectable dosage forms. Unlike traditional freeze drying, which is widely used but time‑intensive and costly, spray drying offers a faster, scalable, and more flexible approach for producing stable dry powders. This technique is particularly valuable for sensitive biologics, such as proteins and monoclonal antibodies, which are prone to degradation in aqueous environments. By removing water and creating precisely engineered particles, spray drying enhances stability, extends shelf life, and reduces reliance on cold‑chain storage.

The technology also enables the development of advanced drug delivery systems, including ultra‑high concentration formulations and encapsulated biologics designed for subcutaneous administration. These innovations support improved patient convenience, such as self‑administration, while maintaining therapeutic performance. As technical challenges are addressed, aseptic spray drying is expected to play an increasingly important role in next‑generation biologic therapies.